← All candidates
6 insider filings on record.
19 filings on record.
INDPIndaptus Therapeutics, Inc.
NasdaqCM · Healthcare · $347.76M
$2.63
+5.20% · Jul 10
6 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 4 moves explained
Reverse-split 3×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what INDP ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$347.76M
Float
3.2M
2% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Earnings · EPS vs forecast
2 of 4 quarters beat
Q4 '25−$9.19 act−$4.83
Q3 '25−$2.98 act+$1.19
Q2 '25−$9.09 act+$0.15
Q1 '25−$8.96 act−$3.92
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice